The efficacy and safety of quadruple therapy without bismuth (concomitant therapy) in the treatment of patients with Helicobacter pylori - associated gastric and duodenal peptic ulcer disease
Aim. Evaluation of the efficacy and safety of quadrupletherapy without bismuth (concomitant therapy) in patients with Helicobacter pylori - associated gastric ulcer and duodenal ulcer in the framework of a comparative research in the population of patients in Russia. Materials and methods. A prospec...
Main Authors: | A M Veliev, I V Maev, D N Andreev, D T Dicheva, A V Zaborovskii, E G Lobanova, L G Bektemirova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2019-08-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/viewFile/33591/pdf |
Similar Items
-
Efficacy of a bismuth-based quadruple therapy regimen for Helicobacter pylori eradication in Saudi Arabia
by: Fahad Alsohaibani, et al.
Published: (2020-01-01) -
Treatment of Helicobacter pylori infection 14‐day concomitant quadruple therapy versus triple therapy: A parallel double‐blind randomized controlled trial
by: Mohamed Hichem Loghmari, et al.
Published: (2023-10-01) -
Comparison of the Dual Therapy of Ilaprazole-Amoxicillin and the Bismuth Quadruple Therapy of Ilaprazole-Amoxicillin-Furazolidone-Bismuth Glycyrrhizinate for Eradication of Helicobacter pylori
by: Min Niu, et al.
Published: (2022-04-01) -
Standard Bismuth Quadruple Therapy versus Concomitant Therapy for the First-Line Treatment of <i>Helicobacter pylori</i> Infection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Rocco Maurizio Zagari, et al.
Published: (2023-05-01) -
Comparison of eradication rates of moxifloxacin–rifabutin triple therapy and bismuth quadruple therapy as second‐line regimens in patients with peptic ulcers
by: Chang Min Lee, et al.
Published: (2022-09-01)